Status:

NOT_YET_RECRUITING

PRevention Of Trauma-related Infections Through an Embedded Clinical Trials Network

Lead Sponsor:

The University of Texas Health Science Center, Houston

Collaborating Sponsors:

Surgical Infection Society

Conditions:

Surgical Site Infection

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

The purpose of this study is to compare the effectiveness of 2 prophylactic antibiotic regimens, ertapenem and cefazolin with metronidazole, in preventing organ space surgical site infections (OS-SSI)...

Eligibility Criteria

Inclusion

  • Trauma laparotomy within 90 minutes of arrival

Exclusion

  • Patients with a known allergy to cephalosporins or β-lactamase inhibitors
  • Prisoners
  • Pregnant and lactating women

Key Trial Info

Start Date :

May 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 31 2027

Estimated Enrollment :

300 Patients enrolled

Trial Details

Trial ID

NCT06920147

Start Date

May 1 2025

End Date

March 31 2027

Last Update

April 11 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The University of Texas Health Science Center at Houston

Houston, Texas, United States, 77030